Hannah Fabikan

Vienna, 1210, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study.

Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study.

Journal: Cancers

Published: November 29, 2025

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 13, 2025

Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report.

Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report.

Journal: Medicine

Published: July 16, 2025

Multidisciplinary treatment of advanced or metastatic ALK-positive non-small cell lung cancer: Real-world data on Brigatinib combined with local therapy.

Multidisciplinary treatment of advanced or metastatic ALK-positive non-small cell lung cancer: Real-world data on Brigatinib combined with local therapy.

Journal: Medicine

Published: April 28, 2025

The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study.

The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study.

Journal: Cancers

Published: April 27, 2025

Prognostic Value of PD-L1, BAP-1 and ILK in Pleural Mesothelioma.

Prognostic Value of PD-L1, BAP-1 and ILK in Pleural Mesothelioma.

Journal: Journal of clinical medicine

Published: October 31, 2024

Sleep-Disordered Breathing in Patients with Chronic Heart Failure and Its Implications on Real-Time Hemodynamic Regulation, Baroreceptor Reflex Sensitivity, and Survival.

Sleep-Disordered Breathing in Patients with Chronic Heart Failure and Its Implications on Real-Time Hemodynamic Regulation, Baroreceptor Reflex Sensitivity, and Survival.

Journal: Journal of clinical medicine

Published: October 29, 2024

Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report.

Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report.

Journal: Cancer treatment and research communications

Published: October 26, 2024

Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations.

Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations.

Journal: Journal of clinical medicine

Published: August 24, 2024

Neoadjuvant therapy in early-stage non-small cell lung cancer: A real-world analysis.

Neoadjuvant therapy in early-stage non-small cell lung cancer: A real-world analysis.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 30, 2024

Prognostic impact of targetable driver alterations in resected early-stage lung cancer.

Prognostic impact of targetable driver alterations in resected early-stage lung cancer.

Journal: Translational lung cancer research

Published: May 16, 2024

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Journal: International journal of molecular sciences

Published: February 26, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026